In this study of a well-defined population of patients with ER+/HER2− ILC, high intratumoral stromal content was found to be a ‘good-prognostic’ factor associated with lower BCM based on a follow-up time of 10 years. This evidence concerns the gene ERBB2 and blue cone monochromacy.